134 related articles for article (PubMed ID: 11688398)
1. Molecular genetic analysis of von Hippel-Lindau disease by denaturing high-performance liquid chromatography.
Menegatti E; Ferrone M; Gallone S; Mameli M; Grosso E; Migone N
Contrib Nephrol; 2001; (136):306-11. PubMed ID: 11688398
[No Abstract] [Full Text] [Related]
2. Molecular diagnosis of von Hippel-Lindau disease.
Murgia A; Martella M; Polli R; Piermarocchi S; Lo Giudice G; Opocher G
Contrib Nephrol; 2001; (136):263-70. PubMed ID: 11688392
[No Abstract] [Full Text] [Related]
3. von Hippel-Lindau disease: genetic and clinical observations.
Iliopoulos O
Front Horm Res; 2001; 28():131-66. PubMed ID: 11443850
[No Abstract] [Full Text] [Related]
4. [Progress in the study of von Hippel-Lindau syndrome].
Chen F; Wu M
Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):236-8. PubMed ID: 9596966
[No Abstract] [Full Text] [Related]
5. New insights into an enigmatic tumour suppressor.
Ratcliffe PJ
Nat Cell Biol; 2003 Jan; 5(1):7-8. PubMed ID: 12511881
[No Abstract] [Full Text] [Related]
6. Clinical review 155: Pheochromocytoma in Von Hippel-Lindau disease.
Hes FJ; Höppener JW; Lips CJ
J Clin Endocrinol Metab; 2003 Mar; 88(3):969-74. PubMed ID: 12629069
[No Abstract] [Full Text] [Related]
7. VHL2C phenotype in a German von Hippel-Lindau family with concurrent VHL germline mutations P81S and L188V.
Weirich G; Klein B; Wöhl T; Engelhardt D; Brauch H
J Clin Endocrinol Metab; 2002 Nov; 87(11):5241-6. PubMed ID: 12414898
[TBL] [Abstract][Full Text] [Related]
8. Gene symbol: VHL. Disease: Von-Hippel-Lindau syndrome.
Baker DW; Cherches IM; Rothberg PG
Hum Genet; 2000 Jun; 106(6):671. PubMed ID: 10942119
[No Abstract] [Full Text] [Related]
9. The challenge of kidney lesions in von Hippel-Lindau disease.
Neumann HP; Riegler P; Huber W; Corradini R; Sessa A; Fontana D; Wetterauer U; Janetschek G
Contrib Nephrol; 2001; (136):193-207. PubMed ID: 11688380
[No Abstract] [Full Text] [Related]
10. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.
Gnarra JR; Duan DR; Weng Y; Humphrey JS; Chen DY; Lee S; Pause A; Dudley CF; Latif F; Kuzmin I; Schmidt L; Duh FM; Stackhouse T; Chen F; Kishida T; Wei MH; Lerman MI; Zbar B; Klausner RD; Linehan WM
Biochim Biophys Acta; 1996 Mar; 1242(3):201-10. PubMed ID: 8603073
[No Abstract] [Full Text] [Related]
11. [File no. 41. VHL (von Hippel-Lindau). Tumor suppressor gene].
Soussi T
Bull Cancer; 2000 Nov; 87(11):771-2. PubMed ID: 11190567
[No Abstract] [Full Text] [Related]
12. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
13. Von Hippel-Lindau (VHL) gene analysis in Italian families with VHL disease.
Montera M; Bellone E; Ajmar F; Mandich P
Contrib Nephrol; 1997; 122():109-11. PubMed ID: 9399050
[No Abstract] [Full Text] [Related]
14. Germline and somatic mutations in von Hippel-Lindau disease gene and its significance in the development of kidney cancer.
Shuin T; Kondo K; Ashida S; Okuda H; Yoshida M; Kanno H; Yao M
Contrib Nephrol; 1999; 128():1-10. PubMed ID: 10597373
[No Abstract] [Full Text] [Related]
15. Von Hippel-Lindau disease: how does one gene cause multiple tumors?
Roach ES
Neurology; 1999 Jul; 53(1):7-8. PubMed ID: 10408528
[No Abstract] [Full Text] [Related]
16. Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing.
Wiesener MS; Eckardt KU
Nephrol Dial Transplant; 2002 Mar; 17(3):356-9. PubMed ID: 11865075
[No Abstract] [Full Text] [Related]
17. Identification of a novel mutation (c279delC) and a polymorphism (c291C>G) in the von Hippel-Lindau gene in Italian patients.
Moore PS; Antonello D; Martignoni G; Racchini C; Ventrucci M; Scarpa A
Hum Mutat; 2000 Jun; 15(6):582. PubMed ID: 10862095
[No Abstract] [Full Text] [Related]
18. Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene.
Cybulski C; Krzystolik K; Murgia A; Górski B; Debniak T; Jakubowska A; Martella M; Kurzawski G; Prost M; Kojder I; Limon J; Nowacki P; Sagan L; Białas B; Kałuza J; Zdunek M; Omulecka A; Jaskólski D; Kostyk E; Koraszewska-Matuszewska B; Haus O; Janiszewska H; Pecold K; Starzycka M; Słomski R; Cwirko M; Sikorski A; Gliniewicz B; Cyryłowski L; Fiszer-Maliszewska Ł; Gronwald J; Tołoczko-Grabarek A; Zajaczek S; Lubiński J
J Med Genet; 2002 Jul; 39(7):E38. PubMed ID: 12114495
[No Abstract] [Full Text] [Related]
19. Von Hippel-Lindau tumor suppressor protein and transcription elongation: new insights into regulation of gene expression.
Bertherat J
Eur J Endocrinol; 1996 Feb; 134(2):157, 159. PubMed ID: 8630511
[No Abstract] [Full Text] [Related]
20. Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A.
Chen F; Slife L; Kishida T; Mulvihill J; Tisherman SE; Zbar B
J Med Genet; 1996 Aug; 33(8):716-7. PubMed ID: 8863170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
